Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results

Cancer Cytopathology

Volumn 123, Issue 6, 2015, Pages 373-381

  Bergeron, Christine ^a   Ikenberg, Hans ^b   Sideri, Mario ^c   Denton, Karin ^d   Bogers, Johannes ^e   Schmidt, Dietmar ^f   Alameda, Francisco ^g   Keller, Thomas ^h   Rehm, Susanne ⁱ   Ridder, Ruediger ^i,j  

^a LABORATOIRE CERBA   (France)

^b CytoMol   (Germany)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d NORTH BRISTOL NHS TRUST   (United Kingdom)

^e Sonic Healthcare   (Belgium)

^f SYNLAB ACADEMY   (Germany)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h ACOMED Statistik   (Germany)

ⁱ Roche Mtm Laboratories   (Germany)

^j F HOFFMANN LA ROCHE LTD   (Switzerland)

more..

Author keywords

atypical squamous cells of undetermined significance (ASC US); cervical cytology; CINtec PLUS; human papillomavirus (HPV); low grade squamous intraepithelial lesion (LSIL); p16 Ki 67 dual stained cytology; Primary ASC US LSIL Marker Study (PALMS); triage

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE OF THE CERVIX; CANCER GRADING; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN TISSUE; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAPANICOLAOU TEST; PATIENT REFERRAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VAGINA SMEAR KIT; VIRUS DETECTION; WART VIRUS; ADOLESCENT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; FOLLOW UP; METABOLISM; MIDDLE AGED; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTODIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84946062137     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21542     Document Type: Article

References (24)

1. Kinney WK, Manos MM, Hurley LB, Ransley JE,. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol. 1998; 91: 973-976.
2. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D,; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007; 197: 346-355.
3. Wright TC Jr, Stoler MH, Behrens CM, Sharma A, Sharma K, Apple R,. Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial. Int J Cancer. 2014; 134: 1835-1843.
4. Massad LS, Einstein MH, Huh WK, et al,; 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013; 121: 829-846.
5. Wright JD, Rader JS, Davila R, et al., Human papillomavirus triage for young women with atypical squamous cells of undetermined significance. Obstet Gynecol. 2006; 107: 822-829.
6. Schiffman M, Solomon D,. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med. 2003; 127: 946-949.
7. Wentzensen N, von Knebel Doeberitz M,. Biomarkers in cervical cancer screening. Dis Markers. 2007; 23: 315-330.
8. Hwang SJ, Shroyer KR,. Biomarkers of cervical dysplasia and carcinoma. J Oncol. 2012; 2012: 507286.
9. Schmidt D, Bergeron C, Denton KJ, Ridder R,; European CINtec Cytology Study Group. p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology: results from the European Equivocal or Mildly Abnormal Papanicolaou Cytology Study. Cancer (Cancer Cytopathol). 2011; 119: 158-166.
10. Dona MG, Vocaturo A, Giuliani M, et al., p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, human papillomavirus detection and genotyping in women undergoing colposcopy. Gynecol Oncol. 2012; 126: 198-202.
11. Ravarino A, Nemolato S, Macciocu E, et al., CINtec PLUS immunocytochemistry as a tool for the cytologic diagnosis of glandular lesions of the cervix uteri. Am J Clin Pathol. 2012; 138: 652-656.
12. Roelens J, Reuschenbach M, von Knebel Doeberitz M, Wentzensen N,., Bergeron C, Arbyn M,. p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis. Cancer (Cancer Cytopathol). 2012; 120: 294-307.
13. Wentzensen N, Schwartz L, Zuna RE, et al., Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012; 18: 4154-4162.
14. Waldstrom M, Christensen RK, Ornskov D,. Evaluation of p16INK4a/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion. Cancer (Cancer Cytopathol). 2013; 121: 136-145.
15. Ordi J, Sagasta A, Munmany M, Rodriguez-Carunchio L, Torne A, del Pino M,. Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy. Cancer (Cancer Cytopathol). 2014; 122: 227-235.
16. Killeen JL, Dye T, Grace C, Hiraoka M,. Improved abnormal Pap smear triage using cervical cancer biomarkers. J Low Genit Tract Dis. 2014; 18: 1-7.
17. Uijterwaal MH, Witte BI, Van Kemenade FJ, et al., Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study. Br J Cancer. 2014; 110: 1579-1586.
18. Ikenberg H, Bergeron C, Schmidt D, et al,; PALMS Study Group. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst. 2013; 105: 1550-1557.
19. Solomon D, Davey D, Kurman R, et al,; Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287: 2114-2119.
20. Petry KU, Schmidt D, Scherbring S, et al., Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 dual-stained cytology. Gynecol Oncol. 2011; 121: 505-509.
21. Wentzensen N, Fetterman B, Tokugawa D, et al., Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening. Cancer (Cancer Cytopathol). 2014; 122: 914-920.
22. Uijterwaal MH, Polman NJ, Witte BI, et al., Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data. Int J Cancer. 2015; 136: 2361-2368.
23. Allia E, Ronco G, Coccia A, et al., Interpretation of p16INK4a/Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology [published online ahead of print December 22, 2014]. Cancer (Cancer Cytopathol). doi: 10.1002/cncy.21511.
24. Kisser A, Zechmeister-Koss I,. A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology. BJOG. 2015; 122: 64-70.